A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

NCT01468181 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

394

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: LY2189265
DRUG: Sulfonylureas (SU)
DRUG: Biguanides (BG)
DRUG: alpha-glucosidase inhibitor (a-GI)
DRUG: Thiazolidinedione (TZD)
DRUG: Glinides

Sponsor

Eli Lilly and Company